tiprankstipranks
Trending News
More News >
Pliant Therapeutics (PLRX)
NASDAQ:PLRX
US Market

Pliant Therapeutics (PLRX) Income Statement

Compare
519 Followers

Pliant Therapeutics Income Statement

Last quarter (Q3 2025), Pliant Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Pliant Therapeutics's net income was $-26.30M. See Pliant Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 1.58M$ 9.69M$ 7.57M$ 41.82M
Gross Profit
$ 0.00$ 1.58M$ 9.69M$ 7.57M$ 41.82M
Operating Expenses
$ 228.37M$ 185.72M$ 136.88M$ 105.11M$ 83.46M
Depreciation and Amortization
$ 2.13M$ 1.84M$ 3.68M$ 1.53M$ 1.31M
EBITDA
$ -205.16M$ -158.23M$ -118.85M$ -95.73M$ -40.34M
Operating Income
$ -228.37M$ -184.15M$ -127.20M$ -97.53M$ -41.65M
Other Income/Expenses
$ 18.06M$ 22.81M$ 3.88M$ 272.00K$ 112.00K
Pretax Income
$ -210.30M$ -161.34M$ -123.32M$ -97.26M$ -41.53M
Net Income
$ -210.30M$ -161.34M$ -123.32M$ -97.26M$ -41.53M
Per Share Metrics
Basic EPS
$ -3.47$ -2.75$ -2.94$ -2.71$ -1.17
Diluted EPS
$ -3.47$ -2.75$ -2.94$ -2.71$ -1.17
Weighted Average Shares Outstanding
60.54M 58.72M 42.02M 35.85M 35.55M
Weighted Average Shares Outstanding (Diluted)
60.54M 58.72M 42.02M 35.85M 35.55M
Currency in USD

Pliant Therapeutics Earnings and Revenue History